Stocktoria

Design Therapeutics, Inc. DSGN

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-03-26

Design Therapeutics, Inc. statistics & valuation

Market cap$833.8M
P / B3.9×
Return on equity-32.8%
Return on capital-37.3%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
-3685.80% 202020212022202320242025
Return on equity (%)
-9.30% -19.30% -24.10% -20.50% -32.80% 202020212022202320242025
Shares outstanding
16.0M 55.4M 55.9M 56.5M 56.8M 60.4M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-22.70% -9.10% -18.60% -23.10% -19.70% -30.90% 202020212022202320242025
Free cash flow margin (%)
-3869.50% 202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$0.77 -$1.14 -$1.19 -$0.88 -$1.22 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Operating margin—————-3685.8%
Net margin—————-3663.7%
FCF margin—————-3869.5%
Return on assets-30.9%-19.7%-23.1%-18.6%-9.1%-22.7%
Return on equity-32.8%-20.5%-24.1%-19.3%-9.3%73.2%
Current ratio17.1429.3129.5831.1072.9615.55

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.